REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
25/08/2025
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
GENOSCIENCE PHARMA
ST13
US500000079258665Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
James R. Robinson Robinson Law Office, PLLC
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Active chemical ingredients used in the manufacture of anti-cancer drugs; chemical products intended for pharmaceutical sciences, namely, chemical additives for use in the manufacture of pharmaceuticals; preserving agents for the pharmaceutical industry, namely, preservatives for use in the pharmaceutical industry; antioxidants for the manufacture of pharmaceutical products; chemical preparations for be used in the manufacture of pharmaceutical products, namely, active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer-related diseases or conditions; chemicals for use in biotechnological product development; enzymes derived from biotechnological processes for industrial use; chemicals used in biotechnological manufacturing processes; diagnostic preparations and diagnostic reagents for scientific or research use; reagents and solvents for sample preparation, modification and manipulation of cells, as well as for the implementation of marking methods, separation, isolation, reproduction and/or cleaning of biopolymers, nucleic acids, proteins, macromolecules, namely, reagents for scientific use and biologically active substances for diagnostic use, namely, biologically active enzymes and microorganisms that are aimed as sanitizing water environments and to treat the activation and optimization of biological filter systems
Classe 5
Pharmaceutical preparations, pharmaceutical products, and pharmaceutical substances, namely, pharmaceutical preparations for the treatment of cancer-related diseases or conditions; pharmaceutical preparations for cancer treatment; biopharmaceutical products for cancer treatment, namely, biological preparations for the treatments of cancer; pharmaceutical products for cancer treatment; pharmaceutical preparations and substances for cancer prevention; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations for cancer prevention and treatment; biotechnological preparations for medical use, namely, biological tissue cultures for medical purposes; diagnostic agents for medical use; strips for medical diagnosis, namely, medical diagnostic test strips for cancer diagnosis; diagnostic preparations for medical use; diagnostic reagents for medical use; diagnostic substances for medical use; pharmaceutical medicine products and diagnostic products for sample preparation, modification and manipulation of cells and for marking, separation, isolation, reproduction and/or cleaning of biopolymers, nucleic acids, proteins, macromolecules and biologically active substances, namely, chemical reagents for medical purposes
Classe 42
Development of new technology on behalf of third parties in the field of genetics and biotechnology; biotechnological processes for regulating, modifying and characterizing of disease conditions, medical research specialized in the biotechnological field with respect to regulating, modifying and characterizing diseases or conditions; research and development for third parties in the field of biotechnology; manufacturing and consolidating upon request of DNA, biological organisms, cells, viruses, pathogens, special cells which have been genetically modified according to the specification of third parties for scientific, medical and laboratory use and for research, namely, medical and scientific laboratory services; gene therapy services for third parties, namely, scientific research and product development regarding DNA, biological organisms, cells, viruses, pathogens and special cells which have been genetically modified for scientific and medical use and for research; scientific and technological services, namely, research and design in the field of medical treatment, namely, cancer treatment; industrial analysis and research services, namely, testing, analysis and evaluation of drugs for treatment of cancer and cancer-related diseases and conditions to assure compliance with industry and regulatory standards; research and development of anti-cancer drugs; development of pharmaceutical preparations and medicines; development of pharmaceutical products; development of chemical compounds, namely, custom design and development of reagents and biochemical assays; research and development of new products for others with respect to chemical compounds for therapeutic use; pharmaceutical drug development services for anti-cancer drugs; evaluation of pharmaceutical products; research in the field of pharmaceutical products, namely, pharmaceutical research and development; pharmaceutical research and development in the field of anti-cancer drugs; pharmaceutical research and development services; pharmaceutical research; carrying out clinical trials for pharmaceutical products, namely, conducting clinical trials for others; conducting cancer treatment clinical trials for others; provision of medical and scientific research information concerning the results of clinical trials for pharmaceutical products; laboratory research services in the field of pharmaceuticals; laboratory research services for cancer treatment; testing, inspection and research services in the field of pharmaceuticals; testing, inspection and research for pharmaceuticals for cancer treatment; biotechnological research services; preparation of reports in the field of biotechnology; research and development in the field of biotechnology; services provided by consultants in the field of biotechnology, namely, scientific research consulting in the field of biotechnology; providing scientific research information in the biochemical and biotechnological fields; product design and development in the field of medical and pharmaceutical diagnostic apparatus
Classe 44
Medical analysis services for diagnosing cancer; medical analysis of RNA or DNA for cancer diagnosis and prognosis; medical analysis services for cancer diagnosis and prognosis; colorectal cancer screening services; medical services for diagnosing diseases; medical diagnosis of cancer-related diseases or conditions; medical testing for the diagnosis and treatment of persons; medical analysis services for cancer diagnosis; medical testing and analysis for diagnostic or treatment purposes
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
25/08/2025
FINAL DECISION TRANSACTION PROCESSED BY IB
03/01/2021
FINAL DISPOSITION NOTICE SENT TO IB
16/12/2020
FINAL DISPOSITION PROCESSED
15/12/2020
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
25/11/2020
REGISTERED-PRINCIPAL REGISTER
25/08/2020
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/06/2020
PUBLISHED FOR OPPOSITION
09/06/2020
NOTIFICATION PROCESSED BY IB
05/06/2020
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/05/2020
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
20/05/2020
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/05/2020
APPROVED FOR PUB - PRINCIPAL REGISTER
04/05/2020
TEAS/EMAIL CORRESPONDENCE ENTERED
30/04/2020
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/04/2020
TEAS REQUEST FOR RECONSIDERATION RECEIVED
30/04/2020
NOTIFICATION OF FINAL REFUSAL EMAILED
13/01/2020
FINAL REFUSAL E-MAILED
13/01/2020
FINAL REFUSAL WRITTEN
13/01/2020
TEAS/EMAIL CORRESPONDENCE ENTERED
18/12/2019
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/12/2019
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/12/2019
REFUSAL PROCESSED BY IB
12/07/2019
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/06/2019
REFUSAL PROCESSED BY MPU
24/06/2019
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/06/2019
NON-FINAL ACTION WRITTEN
03/06/2019
APPLICATION FILING RECEIPT MAILED
24/05/2019
ASSIGNED TO EXAMINER
20/05/2019
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/05/2019
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/05/2019
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.